Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023
(NASDAQ: GMAB) Delayed: 34.22 +0.93 (2.79%)
Previous Close $33.29    52 Week High $ 
Open $34.04    52 Week Low $ 
Day High $34.50    P/E N/A 
Day Low $33.74    EPS $ 
Volume 2,079,451